We are happy to announce the appointment of Dàmi Rebergen to strengthen the bioinformatics capabilities of Cyclomics.
Dàmi Rebergen has a bioinformatics degree from Wageningen University (2019) and has recent experience working at startup and biotech companies in The Netherlands and the UK.
At Cyclomics, Dàmi will perform a key role in the establishment of a user friendly bioinformatic analysis and reporting pipeline for the CyclomicsSeq cancer detection test that the company has developed.
“I am thrilled to be part of the Cyclomics endeavour and look forward to build the next generation of blood-based cancer detection technologies with the Cyclomics team”, says Dàmi.
Besides his bioinformatics role, Dàmi has a strong entrepreneurial mindset.
“We are convinced that his skills and attitude form a very strong addition to the team. Dàmi will be of major help to transition Cyclomics to the next phase of development”, says Jeroen de Ridder, CTO and co-founder of Cyclomics.
We wish Dàmi all the best of luck in his new position!